Detailed information for compound 1058734

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 413.935 | Formula: C21H32ClNO5
  • H donors: 3 H acceptors: 4 LogP: 3.93 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCCCCCCCC/C=C/C(=O)N[C@H]1C[C@]2(O)[C@@H](O[C@H]1O)[C@H](Cl)C=CC2=O
  • InChi: 1S/C21H32ClNO5/c1-2-3-4-5-6-7-8-9-10-11-18(25)23-16-14-21(27)17(24)13-12-15(22)19(21)28-20(16)26/h10-13,15-16,19-20,26-27H,2-9,14H2,1H3,(H,23,25)/b11-10+/t15-,16+,19+,20-,21-/m1/s1
  • InChiKey: BQBLZAMUHGIEFL-JRVIZFGFSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Brugia malayi Telomerase reverse transcriptase 0.773831 0.6883 1
Trypanosoma brucei telomerase reverse transcriptase 0.349615 0.310088 0.5
Onchocerca volvulus Telomerase reverse transcriptase homolog 1.12345 1 0.5
Echinococcus granulosus protection of telomeres protein 1 0.0497725 0.0427631 1
Loa Loa (eye worm) hypothetical protein 0.00995159 0.00726062 1
Loa Loa (eye worm) hypothetical protein 0.00995159 0.00726062 1
Brugia malayi hypothetical protein 0.00995159 0.00726062 0.0105486
Echinococcus multilocularis protection of telomeres protein 1 0.0497725 0.0427631 1
Trypanosoma cruzi telomerase reverse transcriptase, putative 0.349615 0.310088 0.5
Trypanosoma cruzi telomerase reverse transcriptase, putative 0.349615 0.310088 0.5
Schistosoma mansoni hypothetical protein 0.00995159 0.00726062 0.5
Toxoplasma gondii RNA-directed DNA polymerase 0.349615 0.310088 0.5
Leishmania major telomerase reverse transcriptase, putative 0.349615 0.310088 0.5
Giardia lamblia Telomerase catalytic subunit 0.349615 0.310088 0.5
Brugia malayi hypothetical protein 0.00995159 0.00726062 0.0105486
Plasmodium falciparum telomerase reverse transcriptase 0.349615 0.310088 0.5
Plasmodium vivax telomerase reverse transcriptase, putative 0.349615 0.310088 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 1.6 uM Cytotoxicity against human NCI-H187 cells by SRB assay ChEMBL. 19265430
IC50 (functional) = 5.1 uM Antiplasmodial activity after 24 hrs against Plasmodium falciparum K1 by [G-3H]hypoxanthine uptake ChEMBL. 19265430
IC50 (functional) = 13.9 uM Antifungal activity against Candida albicans ChEMBL. 19265430
IC50 (functional) = 15.8 uM Cytotoxicity against human KB cells by SRB assay ChEMBL. 19265430
MIC (functional) = 60.4 uM Antitubercular activity against Mycobacterium tuberculosis H37Ra after 4 days by microplate alamar blue assay ChEMBL. 19265430

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Homo sapiens ChEMBL23 19265430
Candida albicans ChEMBL23 19265430
Plasmodium falciparum 19265430

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.